CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

The Central Bureau of Investigation (CBI) alleged that senior officials of the Central Drugs Standards Control Organisation (CDSCO) colluded with Bengaluru-based pharmaceutical company Biocon Biologics to waive the phase-3 clinical trial of the Insulin Aspart injection, and also “manipulated” the minutes of the subject expert committee (SEC) meeting causing “substantial wrongful gain” to Biocon Biologics.

India’s Joint Drugs Controller Eswara Reddy was arrested on Tuesday by the investigating agency along with L Praveen Kumar, associate vice-president and head of national regulatory affairs (NRA) at Biocon Biologics. Guljit Sethi (alias Guljit Chaudhary) of Bioinnovat Research Services and Dinesh Dua, director of